Cargando…
TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620592/ https://www.ncbi.nlm.nih.gov/pubmed/37226703 http://dx.doi.org/10.3324/haematol.2023.283074 |
| _version_ | 1785130239395889152 |
|---|---|
| author | Gordon, Max J. Bond, David A. Kittai, Adam S. Amirmokhtari, Neda Steinbrunner, Abigail Huffman, Allison Orellana-Noia, Victor Shouse, Geoffrey Cohen, Jonathon B. Phillips, Tycel Danilov, Alexey V. |
| author_facet | Gordon, Max J. Bond, David A. Kittai, Adam S. Amirmokhtari, Neda Steinbrunner, Abigail Huffman, Allison Orellana-Noia, Victor Shouse, Geoffrey Cohen, Jonathon B. Phillips, Tycel Danilov, Alexey V. |
| author_sort | Gordon, Max J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10620592 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106205922023-11-03 TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma Gordon, Max J. Bond, David A. Kittai, Adam S. Amirmokhtari, Neda Steinbrunner, Abigail Huffman, Allison Orellana-Noia, Victor Shouse, Geoffrey Cohen, Jonathon B. Phillips, Tycel Danilov, Alexey V. Haematologica Letter to the Editor Fondazione Ferrata Storti 2023-05-25 /pmc/articles/PMC10620592/ /pubmed/37226703 http://dx.doi.org/10.3324/haematol.2023.283074 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Gordon, Max J. Bond, David A. Kittai, Adam S. Amirmokhtari, Neda Steinbrunner, Abigail Huffman, Allison Orellana-Noia, Victor Shouse, Geoffrey Cohen, Jonathon B. Phillips, Tycel Danilov, Alexey V. TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma |
| title | TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma |
| title_full | TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma |
| title_fullStr | TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma |
| title_full_unstemmed | TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma |
| title_short | TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma |
| title_sort | tres, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620592/ https://www.ncbi.nlm.nih.gov/pubmed/37226703 http://dx.doi.org/10.3324/haematol.2023.283074 |
| work_keys_str_mv | AT gordonmaxj tresavalidatedthreefactorcomorbidityscoreisassociatedwithsurvivalinolderpatientswithmantlecelllymphoma AT bonddavida tresavalidatedthreefactorcomorbidityscoreisassociatedwithsurvivalinolderpatientswithmantlecelllymphoma AT kittaiadams tresavalidatedthreefactorcomorbidityscoreisassociatedwithsurvivalinolderpatientswithmantlecelllymphoma AT amirmokhtarineda tresavalidatedthreefactorcomorbidityscoreisassociatedwithsurvivalinolderpatientswithmantlecelllymphoma AT steinbrunnerabigail tresavalidatedthreefactorcomorbidityscoreisassociatedwithsurvivalinolderpatientswithmantlecelllymphoma AT huffmanallison tresavalidatedthreefactorcomorbidityscoreisassociatedwithsurvivalinolderpatientswithmantlecelllymphoma AT orellananoiavictor tresavalidatedthreefactorcomorbidityscoreisassociatedwithsurvivalinolderpatientswithmantlecelllymphoma AT shousegeoffrey tresavalidatedthreefactorcomorbidityscoreisassociatedwithsurvivalinolderpatientswithmantlecelllymphoma AT cohenjonathonb tresavalidatedthreefactorcomorbidityscoreisassociatedwithsurvivalinolderpatientswithmantlecelllymphoma AT phillipstycel tresavalidatedthreefactorcomorbidityscoreisassociatedwithsurvivalinolderpatientswithmantlecelllymphoma AT danilovalexeyv tresavalidatedthreefactorcomorbidityscoreisassociatedwithsurvivalinolderpatientswithmantlecelllymphoma |